• SENSEX 76,738.17
    585.31 (+0.77%)
  • BANKNIFTY 57,380.60
    208.60 (+0.36%)
  • Gland Pharma
    2,826.60 1,575.00(%)
  • Tata Technolog.
    830.10 890.15(%)
  • IFCI
    103.95 101.60(%)
  • HFCL
    231.40 257.00(%)
  • Lumino Inds
    122.00 119.00(%)
  • Jindal Worldwide
    57.06 47.55(%)
  • Netweb Technol.
    5,424.00 5,810.00(%)
  • Angel One
    308.20 360.20(%)
  • HBL Engineering
    723.85 1,121.95(%)
  • Multi Comm. Exc.
    3,257.00 3,479.80(%)
  • Adani Total Gas
    620.85 859.70(%)
  • Lenskart Solut.
    694.75 680.95(%)
  • Oberoi Realty
    1,932.25 1,985.00(%)
  • RBL Bank
    413.50 410.45(%)
  • Tejas Networks
    613.50 644.75(%)
  • Polycab India
    8,308.55 6,660.50(%)
  • Antelopus Selan
    986.05 357.00(%)
  • Nuvoco Vistas
    353.50 477.35(%)
  • One 97
    1,691.50 1,732.00(%)
  • Reliance Industries
    1,332.30 1,611.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Aurobindo Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4666.0
  • ISIN : INE406A01037
1,637.30 -11 (-0.66%)
  • As on 04 Sep 2026 (EOD)
  • Today’s Low

    1,626.60
  • Today’s High

    1,666.60
  • Open

    1,656.10
  • Perv Close

    1,648.20
  • 52W Low

    1,021.00
  • 52W High

    1,717.00

Key Indicators

  • P/E(TTM)

    35.92

  • Mar.Cap (₹Cr.)

    94,206.62

  • Div & Yield %

    0.25

  • Book Value(₹)

    394.82

  • Debt-Equity Ratio

    -0.66

  • AGM Date

    03-Sep-2026

  • EPS

    45.29

  • P/E Ratio

    35.92

Financials Ratios

  • Debt-Equity Ratio

    0.21

  • Mar.Cap (₹Cr.)

    94,206.62

  • RONW (%)

    11.18

  • ROCE (%)

    13.51

Score Board

  • Equity (₹ in Cr.)

    57.54

  • BV (₹)

    394.80

  • Sales( ₹ in Cr.)

    11,171.72

  • NP (in Cr.)

    2,426.73

  • NP Var(%)

    40.0

  • Div%

    400.0

  • CPS (₹)

    47.10

  • EPS (₹)

    42.20

  • Traded Value (₹ in Lakhs)

    93,613.98

  • 52 Week High

    1,717.00

  • 52 Week Low

    1,021.00

  • Price BSE

    1627.0

  • Price NSE

    1,637.00

  • Market Capital( in Cr.)

    93,613.98

  • P/C Ratio

    34.50

  • P/E Ratio

    38.60

  • Price Vs.BV

    42.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 11,171.72 10,933.30 10,645.64 8,457.00 11,287.14 15,823.68
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 11,171.72 10,933.30 10,645.64 8,457.00 11,287.14 15,823.68
Other Income 587.53 328.12 670.10 443.92 670.99 589.86
Stock Adjustments -46.55 67.66 116.23 263.95 -45.51 -2.99
Total Income 11,712.70 11,329.08 11,431.97 9,164.87 11,912.62 16,410.55
EXPENDITURE :            
Raw Materials 5,311.58 5,675.34 5,964.48 4,755.95 5,800.74 7,241.83
Power and Fuel Cost 174.82 185.59 191.58 167.86 477.99 512.34
Employee Cost 1,161.15 1,063.07 980.56 890.53 1,600.04 1,735.42
Other Manufacturing Expenses 421.52 426.63 414.51 328.42 705.68 925.86
Selling and Administration Expenses 873.42 960.27 822.21 939.38 1,009.36 1,069.84
Miscellaneous Expenses 108.12 132.49 164.49 148.96 249.13 215.57
Employee Benefit Expenses 1,161.15 1,063.07 980.56 890.53 1,600.04 1,735.42
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 8,050.61 8,443.39 8,537.83 7,231.10 9,842.94 11,700.86
Operating Profit 3,662.09 2,885.69 2,894.14 1,933.77 2,069.68 4,709.69
Interest 213.15 230.04 182.60 74.58 16.94 28.68
Gross Profit 3,448.94 2,655.65 2,711.54 1,859.19 2,052.74 4,681.01
Depreciation 285.36 297.20 254.58 243.26 415.26 488.00
Profit Before Tax 3,163.58 2,358.45 2,456.96 1,615.93 1,637.48 4,193.01
Current Tax 746.82 627.37 598.08 412.16 379.70 1,043.34
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.96 -15.71 -95.26 -23.34 -196.93 36.76
Reported Net Profit 2,414.80 1,746.79 1,954.14 1,227.11 1,454.71 3,112.91
Extraordinary Items -11.93 9.46 3.28 9.94 -81.27 -0.13
Adjusted Net Profit 2,426.73 1,737.33 1,950.86 1,217.17 1,535.98 3,113.04
Adjustment below Net Profit 1.08 -5.26 -1.69 8.28 1.69 -6.42
P & L Balance brought forward 20,090.40 18,348.87 16,660.08 15,864.14 14,671.41 11,799.30
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 232.30 0.00 263.66 439.45 263.67 234.38
P & L Balance carried down 22,273.98 20,090.40 18,348.87 16,660.08 15,864.14 14,671.41
Dividend 232.30 0.00 263.66 439.45 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 400.00 0.00 450.00 750.00 900.00 400.00
Dividend Per Share(Rs) 4.00 0.00 4.50 7.50 9.00 4.00
Earnings Per Share-Unit Curr 41.58 30.08 33.35 20.94 24.83 53.13
Earnings Per Share(Adj)-Unit Curr 41.58 30.08 33.35 20.94 24.83 53.13
Book Value 391.14 353.55 336.62 307.80 292.15 271.80
Book Value(Adj)-Unit Curr 391.14 353.55 336.62 307.80 292.15 271.80

Shareholding Pattern

  • Promoter Group

    51.88%

  • Public Share Holding

    48.12%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 17,690,341 17,690,341.00 17,690,341 17,690,341
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 17,690,341 3.07 17,690,341 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 210,859,525 36.65 210,859,525 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 69,972,860 12.16 69,972,860 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 280,832,385 48.81 280,832,385 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 210 0.00 210 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 94,230,349 16.38 94,230,349 674
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 28,711,115 4.99 28,711,115 24
Mutual Funds / UTI 96,131,215 16.71 96,131,215 42
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 19,575,841 3.40 19,575,841 40
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 238,648,730 41.48 238,648,730 781
2] Non Institution
Bodies Corporate 2,847,086 0.49 2,845,976 1,820
Clearing Members 422,236 0.07 422,236 6
Directors of their Relatives 4,010 0.00 4,010 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,161,183 0.38 2,161,183 8,173
Foreign Non Institution Other 410 0.00 410 1
Hindu Undivided Families 827,397 0.14 827,397 3,730
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,883,878 0.33 1,883,878 5
Individuals holding nominal share capital up to Rs. 1 lakh 28,963,904 5.03 28,390,504 224,519
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 155,745 0.03 155,745 17
Others 939,810 0.16 939,810 4
Sub Total 38,206,439 6.64 37,631,929 238,278
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 575,377,895 100.00 574,803,385 239,073

Company Background

Aurobindo Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Aurobindo Pharma Ltd
  • BSE Code : 4666.0
  • ISIN : INE406A01037
  • Incorporation Year

    1986

  • Registered Office

    Plot No 2 Maitrivihar
    Behind Maithri Vanam Ameerpet, Hyderabad,
    Telangana-500038

  • Telephone

    91-40-23736370

  • FAX

    91-40-23747340

  • Chairman

    M R Kumar

  • Managing Director

  • Company Secretary

    B Adi Reddy

  • Auditor

    Deloitte Haskins & Sells

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Aurobindo Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Aurobindo Pharma 1,627.00 11,759.25 11,171.72 36.11 12.91
Abbott India 25,878.50 7,217.19 6,929.05 34.06 43.78
Astrazeneca Phar 6,946.95 2,304.07 2,275.58 102.39 27.86
Glaxosmi. Pharma 2,935.35 3,932.76 3,790.20 46.89 58.17
Novartis India 1,614.95 398.23 356.27 40.78 16.64
Cipla 1,389.00 20,102.60 18,979.95 36.50 13.88
Bliss GVS Pharma 636.90 773.53 729.81 59.14 12.51
Amrutanjan Healt 507.20 520.13 502.55 27.17 24.16
Fermenta Biotec. 502.80 474.15 450.25 23.47 18.77
Guj. Themis Bio. 425.00 152.47 150.80 113.64 27.21
Ambalal Sarabhai 43.88 19.52 3.94 81.26 6.77